BobbieJoRimelMD(She/Her)

PubMed

• NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endomet...
  Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan, Nitya Alluri, Mark Borowsky, John Moroney, Andrea Wahner Hendrickson, Floor Bac...> ;Cancer. 2024 Apr 15
• Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(ade...
  Perhanidis, J., Ghazarian, A., Du, E., Wang, T., Song, J., Golembesky, A., Kalilani, L., Rimel, B., Chase, D., Hurteau, J., Salani, R., Monk, B.> ;Gynecologic Oncology Reports. 2024 Feb 1
• Inequities in colorectal and breast cancer screening: At the intersection of race/ethnicity, sexuality, and gender.
  Emmeline Lin, Patrycja Sleboda, Bobbie J Rimel, Geetanjali D Datta> ;SSM - Population Health. 2023 Dec 1
• 1 citations
  Sexual orientation and gender identity inequities in cervical cancer screening by race and ethnicity.
  Emmeline Lin, Patrycja Sleboda, Bobbie J Rimel, Jarvis T Chen, Diana V Hernandez, Geetanjali D Datta> ;Cancer Causes & Control. 2024 Jan 1
• 5 citations
  The association of black race with receipt of hysterectomy and survival in low-risk endometrial cancer.
  Kristin N Taylor, Andrew Li, Michael Manuel, Bobbie Jo Rimel, Kenneth H Kim> ;Gynecologic Oncology. 2023 Aug 1
• 2 citations
  Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations.
  Bobbie J Rimel, Erin K Crane, June Hou, John Nakayama, Jennifer MacDonald, Kathleen Lutz, Vicky Makker, Roisin E O'Cearbhaill> ;Gynecologic Oncology. 2023 Jul 1
• 3 citations
  Safety and management of niraparib monotherapy in ovarian cancer clinical trials.
  Bradley J Monk, Antonio González-Martin, Lynn Buckley, Ursula A Matulonis, B J Rimel, Xiaohua Wu, Kathleen N Moore, Mansoor R Mirza> ;International Journal of Gynecological Cancer. 2023 Jun 5
• 2 citations
  Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in GermlineWild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects.
  Mansoor Raza Mirza, Gabriel Lindahl, Sven Mahner, Andrés Redondo, Michel Fabbro, Bobbie J Rimel, Jørn Herrstedt, Amit M Oza, Ulrich Canzler, Jonathan S Berek, Antonio ...> ;Cancer Research Communications. 2022 Nov 1
• 5 citations
  Current gaps and opportunities in screening, prevention, and treatment of cervical cancer.
  Bobbie J Rimel, Charles A Kunos, Nikeya Macioce, Sarah M Temkin> ;Cancer. 2022 Dec 1
• 2 citations
  A case of endometrial intraepithelial neoplasia in a transgender man on testosterone therapy.
  Reed M O'Connor, Marla E Scott, Rania Bakkar, B J Rimel> ;Gynecologic Oncology Reports. 2022 Aug 1
• 6 citations
  DNA methylation and transcriptomic features are preserved throughout disease recurrence and chemoresistance in high grade serous ovarian cancers.
  Nicole Gull, Michelle R Jones, Pei-Chen Peng, Simon G Coetzee, Tiago C Silva, Jasmine T Plummer, Alberto Luiz P Reyes, Brian D Davis, Stephanie S Chen, Kate Lawrenson,...> ;Journal of Experimental & Clinical Cancer Research. 2022 Jul 27
• 24 citations
  A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
  Mortlock, S., Corona, R., Kho, P., Pharoah, P., Seo, J., Freedman, M., Gayther, S., Siedhoff, M., Rogers, P., Leuchter, R., Walsh, C., Cass, I., Karlan, B., Rimel, B.,...> ;Cell Reports. Medicine. 2022 Mar 15
• 1 citations
  Evaluation of patterns of progression on poly (ADP-ribose) polymerase inhibitor (PARPi) maintenance in ovarian cancer: a cross-sectional study.
  Victoria R Cerda, Diana Lu, Marla Scott, Kenneth H Kim, Bobbie Jo Rimel, Mitchell Kamrava> ;International Journal of Gynecological Cancer. 2022 Feb 1
• 1 citations
  Ovarian Transposition Before Pelvic Radiation Therapy: Spatial Distribution and Dose Volume Analysis
  Yaniv R. Raphael, Jennifer M. Steers, Diana J. Lu, John H. Lewis, John J. DeMarco, Benedick A. Fraass, Bobbie J. Rimel, Roja Zakariaee, Mitchell Kamrava, Katelyn M. At...> ;Advances in Radiation Oncology. 2021 Oct 1
• 12 citations
  Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
  Christine Walsh, Mitchell Kamrava, Andre Rogatko, Sungjin Kim, Andrew J. Li, Ilana Cass, Beth Y. Karlan, Bobbie J. Rimel> ;Plos One. 2021 Jun 3
• 29 citations
  Single-cell transcriptomics identifies gene expression networks driving differentiation and tumorigenesis in the human fallopian tube.
  Huy Q. Dinh, Xianzhi Lin, Forough Abbasi, Robbin Nameki, Marcela A. Haro, Claire E. Olingy, Heidi Chang, Lourdes Hernandez, Simon A. Gayther, Kelly N. Wright, Paul-Jos...> ;Cell Reports. 2021 Apr 13
• 21 citations
  Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial
  Mansoor Raza Mirza, Benedict B. Benigno, Anne Dørum, Sven Mahner, Paul Bessette, IM Bover Barcelo, Dominique Berton-Rigaud, Jonathan A. Ledermann, Bobbie J. Rimel, Jør...> ;Gynecologic Oncology. 2020 Nov 1
• 3 citations
  Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers.
  Abigail Fong, Ilana Cass, Catherine John, J. Gillen, Kathleen M Moore, Alexandra Gangi, Christine Walsh, Andrew J. Li, Bobbie J. Rimel, Beth Y. Karlan, Farin Amersi> ;The American Surgeon. 2020 Oct 26
• 1 citations
  21 Code of Federal Regulations Part 11-Compliant Digital Signature Solution for Cancer Clinical Trials: A Single-Institution Feasibility Study.
  Therica M. Miller, Jenny Lester, Lorna Kwan, Megha Tandel, Beth Y. Karlan, Bobbie J. Rimel> ;JCO Clinical Cancer Informatics. 2020 Sep 24
• Niraparib in the treatment of previously treated advanced ovarian, fallopian tube or primary peritoneal cancer.
  Bobbie J. Rimel, Lauren Dockery, Leslie M Randall, Kathleen N. Moore> ;Future Oncology. 2020 Sep 3
• 10 citations
  Take me to your leader: Reporting structures and equity in academic gynecologic oncology.
  Sarah M. Temkin, Lisa Rubinsak, Michelle F. Benoit, Linda Hong, Uma Chandavarkar, Christine A. Heisler, Laurel K. Berry, Bobbie J. Rimel, William P. McGuire> ;Gynecologic Oncology. 2020 Apr 7
• 89 citations
  PARP Inhibition in Cancer: An Update on Clinical Development
  Esha Sachdev, Roya Tabatabai, Bobbie J. Rimel, Monica M. Mita> ;Targeted Oncology. 2019 Dec 1
• 14 citations
  Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer
  Koji Matsuo, James C. Cripe, Katherine C. Kurnit, Michiko Kaneda, Audrey S. Garneau, Gretchen E. Glaser, Aaron Nizam, Rachel M. Schillinger, Michelle Kuznicki, Akira Y...> ;Gynecologic Oncology. 2019 Oct 1
• 6 citations
  Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination.
  Neeraj K. Aryal, Vinod Pant, Amanda R. Wasylishen, Bobbie J. Rimel, Laura Baseler, Adel K. El-Naggar, David G. Mutch, Paul J. Goodfellow, Swathi Arur, Guillermina Lozano> ;Cancer Research. 2019 May 15
• 287 citations
  Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
  Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, David Miller, N.G. Cloven, Gini F. Fleming, Andrea E. Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro,...> ;The Lancet. Oncology. 2019 May 1
• Join now to see all

Journal Articles

• Thrombocytosis at Secondary Cytoreduction for Recurrent Ovarian Cancer Predicts Suboptimal Resection and Poor Survival  
  Cohen JG, Tran A, Rimel, BJ, Cass I, Walsh CS, Karlan BY, Li A, Gynecol Oncol, 1/1/2014
• Post treatment surveillance of type II endometrial cancer patients  
  Zakhour M, Li AJ, Walsh CS, Cass, I, Karlan BY, Rimel BJ, Gynecol Oncol, 12/1/2013
• A Cost Analysis of Colposcopy following Abnormal Cytology in Post Treatment Cancer Surveillance for Cervical Cancer  
  Tergas A, Havrilesky L, Guntupalli S, Huh W, Massad L, Nickles-Fader A, Rimel BJ, Gynecol Oncol, 9/1/2013
• Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment  
  Rimel BJ, Ferda A, Erwin J, Dewdney S, Seamon, Gao F, DeSimone C, Cotney K, Huh W, Massad LS, Obstet Gynecol, 9/1/2011
• Inferior vena cava filter placement in the gynecologic oncology patient: A fifteen year institutional experience  
  Dewdney SB, Benn, T, Rimel BJ, Gao F, Saad N, Vedanthan S, Mutch DG, Zighelboim I, Gynecol Oncol, 5/1/2011
• Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 RSK4 in endometrial cancers  
  Dewdney SB, Rimel BJ, Thaker P, Thompson D, Schmidt A, Huettner P, Mutch D, Gao F, Goodfellow PJ, Clinical Cancer Research, 4/7/2011
• The role of neoadjuvant chemotherapy in the management of patients with advanced ovarian cancer: Survey results from the members of the Society of Gynecologic Oncologists  
  Dewdney SB, Rimel BJ, Reinhart AJ, Kizer NT, Brooks RA, Massad LS, Zighelboim I, Gynecol Oncol, 10/1/2010
• Absence of MGMT promoter methylation in endometrial cancer  
  Rimel BJ, Huettner P, Powell M, Mutch D, Goodfellow PJ, Gynecol Oncol, 7/1/2010
• Discussion: 'Biomarkers for detection of early ovarian cancer' by Nosov et al  
  Massad LS, Parks L, Rimel BJ, Kizer N, Ogutha J, Amer J Obstet Gynecol, 6/1/2009
• Progestin treatment induces apoptosis and modulates transforming growth factor-beta in the uterine endometrium  
  Rodriguez GC, Rimel BJ, Watkin W, Turbov JM, Barry C, Du H, Maxwell GL, Cline JM, Cancer Epidemiol Biomarkers Prev, 3/1/2008
• Update: Endometrial Cancer  
  Rimel BJ, Mutch D, OBG Management, 1/1/2008
• Cancer of the cervix: current management and new approaches  
  Shivnani AT, Rimel BJ, Schink J, Small W Jr, Oncology, 1/1/2006
• Lentivirus vectors using human and simian immunodeficiency virus elements  
  White SM, Renda M, Nam NY, Klimatcheva E, Zhu Y, Fisk J, Halterman M, Rimel BJ, Federoff H, Pandya S, Rosenblatt JD, Planelles V, J Virol, 1/1/1999
• Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr  
  Shostak LD, Ludlow J, Fisk J, Pursell S, Rimel BJ, Nguyen D, Rosenblatt JD, Planelles V, Exp Cell Res, 1/1/1999
• Inhibition of HIV type 1 infection with a RANTES-IgG3 fusion protein  
  Challita-Eid PM, Klimatcheva E, Day BT, Evans T, Dreyer K, Rimel BJ, Rosenblatt JD, Planelles V, AIDS Res Hum Retroviruses, 1/1/1998
• Join now to see all